Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
2
Oregon Venture Fund, Portland Seed Fund
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Backed byfrom the funds' portfolios and accelerator catalogs
Oregon Venture Fund 
Portland Seed Fund Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Nucleai helps biopharma answer two critical questions: why does a therapy work, and which patients will benefit?
Manas AI is the AI-native biopharmaceutical company. We combine pioneering AI technology with the first principles of chemistry, physics…
Atomwise is a San Francisco company founded in 2012 that pioneered the use of convolutional neural networks for structure-based small…
To find the right drug for the right target…. Deep Apple Therapeutics is discovering new small-molecule therapeutics with unprecedented…
PROSION Therapeutics is a drug development company that utilises cutting-edge technology to unlock so far undruggable targets and address…
We study the genetic causes of inherited disease to push drug discovery forward with the right targets and predictors of drug response from…
News
InVivo Biosystems
The Nature Index tracks the affiliations of scientific articles from high-quality publications. The research profile for InVivo Biosystems reflects the research output of authors from InVivo Biosystems who published articles in the 145 journals included i
Read more
Report
Zebrafish Husbandry 101: How to Properly Sterilize Zebrafish Tanks
Maintaining a clean and sterile environment is essential for zebrafish research facilities. Proper sterilization of zebrafish tanks not only prevents the spread of harmful pathogens but also ensures the overall health and well-being of the fish, contribut
Read more
Report
Press Release: Brian Pollok Appointed to InVivo Biosystems Board of Directors
InVivo Biosystems, a leader in preclinical development and genome editing, announces the appointment of Brian Pollok, Ph.D., to its Board of Directors. EUGENE, OR, UNITED STATES, February 4, 2025 /EINPresswire.com/ - InVivo Biosystems, a leader in preclin
Read more
Report
Nematode Gene Editing Services at InVivo Biosystems
At InVivo Biosystems (formerly NemaMetrix), our passion for innovation drives us to continually expand the horizons of genetic research. While Caenorhabditis elegans (C. elegans) has long been a cornerstone of our model organism expertise, we are thrilled
Read more
Report
The Power of Embryo Toxicity Testing in Modern Toxicology
Zebrafish embryos are one of the most powerful models for toxicity testing, offering a reliable and efficient method of determining toxicity levels for various substances. What makes this model stand out? Its speed, cost-effectiveness, and ability to prov
Read more
Report
2024 Nobel Prize Celebrates C. elegans Research: A Model Organism Changing the Face of Genetic Discovery
The 2024 Nobel Prize in Physiology or Medicine has been awarded to groundbreaking microRNA research utilizing Caenorhabditis elegans (C. elegans), a nematode that has been at the heart of scientific discovery for decades. This humble worm, often overlooke
Read more
Report
PRV Program Under Review: Impact On Rare Drug Development
FDA Priority Review Voucher (PRV) Program Under Review: What's Next for Rare Pediatric Disease Drug Development? As of September 27, 2024, the FDA's Priority Review Voucher (PRV) program for rare pediatric disease drugs is set to phase out on December 20,
Read more
Report
Humanized Models: Shaping the Future of Drug Discovery and Development
Humanized in vivo Models: Shaping the Future of Drug Discovery and Development In the pursuit of novel therapies and deeper insights into human diseases, the use of model organisms has been fundamental. While rodent models have driven significant advancem
Read more
Report
Show more news